| Discovery Fine Chemicals Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() | www.discofinechem.com | |||
![]() | +44 (1202) 874-517 | |||
![]() | +44 (845) 094-4385 | |||
![]() | pjc@discofinechem.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Medilink Pharmachem | India | Inquire | ||
|---|---|---|---|---|
![]() | www.medilinkpharma.com | |||
![]() | +91 (79) 3007-0133 | |||
![]() | +91 (79) 4007-4175 | |||
![]() | exports@medilinkpharma.com | |||
| Chemical distributor since 1996 | ||||
| chemBlink Standard supplier since 2014 | ||||
| Ascent Scientific | UK | Inquire | ||
|---|---|---|---|---|
![]() | www.ascentscientific.com | |||
![]() | +44 (117) 982-9988 | |||
![]() | +44 (2030) 700-369 | |||
![]() | customerservice@ascentscientific.co.uk | |||
| Chemical manufacturer | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Toronto Research Chemicals Inc. | Canada | Inquire | ||
|---|---|---|---|---|
![]() | www.trc-canada.com | |||
![]() | +1 (416) 665-9696 | |||
![]() | +1 (416) 665-4439 | |||
![]() | info@trc-canada.com | |||
| Chemical manufacturer since 1982 | ||||
| Classification | API >> Urinary system medication >> Diuretic |
|---|---|
| Name | Amiloride hydrochloride |
| Synonyms | N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride |
| Molecular Structure | ![]() |
| Molecular Formula | C6H8ClN7O.HCl |
| Molecular Weight | 266.09 |
| CAS Registry Number | 2016-88-8 |
| EC Number | 217-958-2 |
| Melting point | 293-294 °C |
|---|---|
| Water solubility | <0.1 g/100 mL at 19.5 °C |
| Hazard Symbols | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R25 Details | ||||||||||||||||||||||||
| Safety Statements | S36;S45 Details | ||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| Transport Information | UN 2811 | ||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Amiloride hydrochloride |